1-5865311-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000460696.1(NPHP4):n.1771C>T variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.402 in 1,482,882 control chromosomes in the GnomAD database, including 122,548 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.35 ( 10196 hom., cov: 33)
Exomes 𝑓: 0.41 ( 112352 hom. )
Consequence
NPHP4
ENST00000460696.1 non_coding_transcript_exon
ENST00000460696.1 non_coding_transcript_exon
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.09
Publications
10 publications found
Genes affected
NPHP4 (HGNC:19104): (nephrocystin 4) This gene encodes a protein involved in renal tubular development and function. This protein interacts with nephrocystin, and belongs to a multifunctional complex that is localized to actin- and microtubule-based structures. Mutations in this gene are associated with nephronophthisis type 4, a renal disease, and with Senior-Loken syndrome type 4, a combination of nephronophthisis and retinitis pigmentosa. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2014]
NPHP4 Gene-Disease associations (from GenCC):
- nephronophthisis 4Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), G2P
- Senior-Loken syndrome 4Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- nephronophthisis 1Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Senior-Loken syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 1-5865311-G-A is Benign according to our data. Variant chr1-5865311-G-A is described in ClinVar as [Benign]. Clinvar id is 260559.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.415 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NPHP4 | NM_015102.5 | c.3645-38C>T | intron_variant | Intron 26 of 29 | ENST00000378156.9 | NP_055917.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NPHP4 | ENST00000378156.9 | c.3645-38C>T | intron_variant | Intron 26 of 29 | 1 | NM_015102.5 | ENSP00000367398.4 | |||
NPHP4 | ENST00000378169.7 | n.*2546-38C>T | intron_variant | Intron 23 of 26 | 1 | ENSP00000367411.3 | ||||
NPHP4 | ENST00000489180.6 | n.*1456-38C>T | intron_variant | Intron 29 of 32 | 2 | ENSP00000423747.1 |
Frequencies
GnomAD3 genomes AF: 0.353 AC: 53654AN: 152066Hom.: 10194 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
53654
AN:
152066
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.389 AC: 48526AN: 124902 AF XY: 0.393 show subpopulations
GnomAD2 exomes
AF:
AC:
48526
AN:
124902
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.408 AC: 542555AN: 1330696Hom.: 112352 Cov.: 29 AF XY: 0.409 AC XY: 264386AN XY: 647122 show subpopulations
GnomAD4 exome
AF:
AC:
542555
AN:
1330696
Hom.:
Cov.:
29
AF XY:
AC XY:
264386
AN XY:
647122
show subpopulations
African (AFR)
AF:
AC:
6162
AN:
30994
American (AMR)
AF:
AC:
12400
AN:
33846
Ashkenazi Jewish (ASJ)
AF:
AC:
10025
AN:
21768
East Asian (EAS)
AF:
AC:
9382
AN:
35282
South Asian (SAS)
AF:
AC:
30507
AN:
70694
European-Finnish (FIN)
AF:
AC:
16910
AN:
39836
Middle Eastern (MID)
AF:
AC:
1654
AN:
4074
European-Non Finnish (NFE)
AF:
AC:
433336
AN:
1039052
Other (OTH)
AF:
AC:
22179
AN:
55150
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
16088
32176
48265
64353
80441
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
13890
27780
41670
55560
69450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.353 AC: 53673AN: 152186Hom.: 10196 Cov.: 33 AF XY: 0.355 AC XY: 26412AN XY: 74398 show subpopulations
GnomAD4 genome
AF:
AC:
53673
AN:
152186
Hom.:
Cov.:
33
AF XY:
AC XY:
26412
AN XY:
74398
show subpopulations
African (AFR)
AF:
AC:
8630
AN:
41542
American (AMR)
AF:
AC:
5651
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
1597
AN:
3470
East Asian (EAS)
AF:
AC:
1383
AN:
5166
South Asian (SAS)
AF:
AC:
2072
AN:
4818
European-Finnish (FIN)
AF:
AC:
4529
AN:
10598
Middle Eastern (MID)
AF:
AC:
116
AN:
294
European-Non Finnish (NFE)
AF:
AC:
28435
AN:
67978
Other (OTH)
AF:
AC:
759
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1776
3552
5328
7104
8880
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
528
1056
1584
2112
2640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1305
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
May 13, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Nephronophthisis 4 Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.